Long Grove Drug Patent Portfolio
Long Grove owns 1 orange book drug protected by 7 US patents Given below is the list of Long Grove's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10159657 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10226436 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10420735 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US10568850 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US11413259 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US11602508 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
| US12245996 | Norepinephrine compositions and methods therefor | 30 Jan, 2038 | Active |
Latest Legal Activities on Long Grove's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Long Grove.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 11 Mar, 2025 | US12245996 |
| Mail Patent eGrant Notification | 11 Mar, 2025 | US12245996 |
| Patent Issue Date Used in PTA Calculation | 11 Mar, 2025 | US12245996 |
| Recordation of Patent eGrant | 11 Mar, 2025 | US12245996 |
| Email Notification | 11 Mar, 2025 | US12245996 |
| Recordation of Patent Grant Mailed | 11 Mar, 2025 | US12245996 |
| Issue Notification Mailed | 19 Feb, 2025 | US12245996 |
| Email Notification | 19 Feb, 2025 | US12245996 |
| Application Is Considered Ready for Issue | 03 Feb, 2025 | US12245996 |
| Dispatch to FDC | 03 Feb, 2025 | US12245996 |
| Issue Fee Payment Received | 31 Jan, 2025 | US12245996 |
| Issue Fee Payment Verified | 31 Jan, 2025 | US12245996 |
| Mail Corrected Notice of Allowance | 20 Dec, 2024 | US12245996 |
| Corrected Notice of Allowance | 19 Dec, 2024 | US12245996 |
| Mail Notice of Allowance | 18 Dec, 2024 | US12245996 |
Long Grove's Family Patents
Long Grove Drug List
Given below is the complete list of Long Grove's drugs and the patents protecting them.
1. Norepinephrine Bitartrate In 0.9% Sodium Chloride
Norepinephrine Bitartrate In 0.9% Sodium Chloride is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10159657 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US10226436 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US10420735 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US10568850 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US11413259 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US11602508 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
| US12245996 | Norepinephrine compositions and methods therefor |
30 Jan, 2038
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norepinephrine Bitartrate In 0.9% Sodium Chloride's drug page